杨西林 教授
流行病与卫生统计学系
电子邮件:yangxilin@tmu.edu.cn
简历
研究方向:
杨西林教授于2002年在澳大利亚墨尔本大学获得流行病学博士学位；随后于香港中文大学医学院从事博士后等研究工作；现就职于天津医科大学公共卫生学院，并任流行病学与卫生统计学系教授、系主任。
主要研究领域为2型糖尿病及妊娠糖尿病流行病学，并致力于妊娠糖尿病及其不利结局的防控。2000年，与合作者一同建立了天津市妊娠糖尿病筛查和管理系统，形成了“天津市孕期糖尿病研究”项目，并以主要负责人和共同负责人的身份在该人群中完成了2项转化研究；其中“天津市三级孕期保健网络对妊娠期糖尿病的联合干预效果的随机对照研究”项目，检验了妊娠期间的生活方式强化干预手段对改善分娩结局的有效性，同时评估其成本效益；另一项“天津市妊娠糖尿病干预研究”项目则检验了产后干预对降低妊娠糖尿病母亲未来发生糖尿病的危险的作用。
学习经历
2000-2002
博士(流行病学),墨尔本大医学院,澳大利亚,维多利亚州;论文题目:天津妊娠糖尿病研究
1998-2000
博士(流行病学),蒙纳什大学医学院， 澳大利亚,维多利亚州;论文题目:天津妊娠糖尿病研究 (转学至墨尔本大学)
1988-1991
工学硕士(营养与食品卫生学),天津轻工业学院(现天津科技大学).论文题:社会营养经济检测:应用和实践
1980-1983
医学毕业证书,承德医学院,河北承德
工作经历
2011.11-
教授和系主任,天津医科大学公共卫生学院流行病与卫生统计学系
2007.3-2011.10
研究助理教授,香港中文大学医学院医学及治疗学系,中国香港
2005.3-2007.2
博士后研究员,香港中文大学医学院内科学及治疗学系,中国香港
2003.2- 2005.2
副研究员,香港中文大学公共卫生学院统计学与流行病学中心,中国香港
2001.11-2002.12
研究分析员,澳洲华人健康促进会,澳大利亚维多利亚
2000.10-2001.10
研究分析员,(兼职: 0.5),澳洲华人健康促进会,澳大利亚维多利亚
1997.2-1998.1
访问研究员,蒙纳什大学医学系,澳大利亚维多利亚
1994.6-1997.1
主管技师,天津市食品卫生监督检验所
1991.6-1994.5
技师,天津市食品卫生监督检验所
1985.5-1988.8
住院医师,榆次人民医院儿科和内科,中国山西
1983.8-1985.4
住院医师,新城县医院内科，中国河北
主要承担或参与的课题
2019-
国家自然科学基金面上项目：肠道菌群与胆汁酸的串话在妊娠期糖尿病发病机制中的作用(项目批准号：**)，主持，57.0****民币, 2019.01.01-2022.12.31。
2018-
国家重大研发计划：“2型糖尿病、糖尿病高风险和妊娠糖尿病危险因素的早期行为干预适宜技术及疗效评价研究”子课题三 “妊娠糖尿病相关危险因素的控制现况、风险预测模型、干预适宜技术与管理策略研究”(项目编号: 2018YFC**)（主持），215****民币,2018.09.01-2020.12.31。
2018-
香港中文大学： 合作分析妊娠期糖尿病遗传数据(项目编号: TT**)，主持，人民币10.0万, 2018.01.01-2023.12.31。
2018-
国家自然科学基金青年基金项目：全氟化合物对妊娠期糖尿病发生及对子代近期和远期健康风险的影响及机制研究 （项目编号：**）,主持:冷俊宏,参与，24****民币，2018.01.01-2020.12.31。
2013-
European Foundation for the Study of Diabetes (EFSD)/Chinese Diabetes Society (CDS)/Lilly Program for Collaborative Research between China and Europe，�170,000– Co-I (PI:Huiguang Tian/Gang Hu) “Tianjin gestational diabetes prevention program follow-up study”, From
2012-
Tianjin Medical University, Seeding G rant, CNY Yuan 300,000 – Principal Investigator, “A pilot trial of prevention of liver cancer among patients with Type 2 diabetes and Hepatitis B Virus Infection”.
2010-
Hong Kong Research G rant CouncilDirect Allocation, HKD$32,000 – Principal Investigator; Project title: “Impacts of hyperglycaemia and insulin treatment on the insulin-like growth factor pathway for cancer in Type 2 diabetes” (Ref No. 2009.2.010) (from
2010-
International Diabetes Federation (IDF) and Lilly’s Bringing Research In Diabetes to Global Environments and Systems (BRiDGES), US$393,812 –Co-Principal Investigator (with Huiguang Tian); Project title: “A randomized translational study to examine the effects of shared care versus usual care in management of gestational diabetes in a three-tier prenatal care network in Tianjin, China” (Ref No. LT09-227) (01 July 2010 to 31December2013)
2009-
European Foundation for the Study of Diabetes (EFSD) and the Chinese Diabetes Society (CDS) and Lilly Research Grant, Euro 200,000 – Project Advisor (PI:Huiguang Tian&JaakkoTuomilehto&Gang Hu); Project title: “A Study of the Interaction of Lifestyle and Genetic Factors on the Incidence of Type 2 Diabetes in Tianjin Women with Gestational Diabetes”(
2009-
Hong Kong Research G rant CouncilDirect Allocation, HKD$50,000 – Principal Investigator; Project title: “Use of oral anti-diabetic drugs and risks of cancer in type 2 diabetes” (Ref No. 2008.1.043) (from
2009-
Food and Health Bureau,Hong Kong.HKD$ 335,715 – Co-Investigator (PI: Alice PS Kong); Project title: “Prevalence of melamine incident and follow-up studies in Hong Kong school children”(Project No. MD08668, from
2008-
Hong Kong Research G rant Council – General Research Fund, HKD$847,818 – Co-Investigator (PI: Wing-Hung Tam); Project title: “Maternal hyperglycaemia and cardio-metabolic risk of children offspring – a follow-up on HAPO study”. (Ref No. CU08734, From
2007-
Hong Kong Research G rant Council (Earmarked Grant), HKD$758,340 – Co-Investigator (PI: Alice P Kong);Project title: “Sleep duration, neurohormonal dysregulation and obesity in Hong Kong children and adolescents”. (RGC ref: CU06465, from
1999
天津市科技委员会,面上，人民币Y48,000 –调查员(第二承担人);项目:强化治疗妊娠期糖耐量减低孕妇对妊娠结局的影响研究, “天津妊娠糖尿病研究”子项目，1999-2001
近五年发表文章(主要作者论文)
1. Huo X#, Li J#, Cao YF, Li SN, Shao P, Leng J, Li W, Liu J, Yang K, Ma RCW, Hu G, Fang ZZ*, Yang X*. Trimethylamine-N-oxide metabolites in the early pregnancy and risk of gestational diabetes: a nested case control study. J Clin Endocrinol Metab.2019 Aug 2. pii: jc.2019-00710. doi: 10.1210/jc.2019-00710.(2-y IF: 5.605, 5-y IF: 5.960)
2. Yang W#, Liu J#, Li J, Liu J, Liu H, Wang Y, Leng J, Wang S, Chen H, Chan JCN, Yu Z, Hu G, Yang X*. Interactive effects of prepregnancy overweight and gestational diabetes on macrosomia and large for gestational age: A population-based prospective cohort in Tianjin, China. Diabetes Res Clin Pract. 2019 Aug;154:82-89. doi: 10.1016/j.diabres.2019.06.014. (2-y IF: 3.239; 5-y IF: 3.587)
3. Cao YF#, Li J#, Zhang Z#, Liu J, Sun XY, Feng XF, Luo HH, Yang W, Li SN, Yang X*, Fang ZZ*. Plasma Levels of Amino Acids Related to Urea Cycle and Risk of Type 2 Diabetes Mellitus in Chinese Adults. Front Endocrinol (Lausanne). 2019 Feb 18;10:50. doi: 10.3389/fendo.2019.00050. eCollection 2019. (2-y IF: 3.643).
4. Ren Y#, Gao L#, Guo X, Huo X, Lu J, Li J, Ji L*,Yang X*.Interactive effect of serum uric acid and total bilirubin for micro-vascular disease of type 2 diabetes in China.J Diabetes Complications.2018 Nov;32(11):1000-1005. doi: 10.1016/j.jdiacomp.2018.09.002. Epub 2018 Sep 7. (2-y IF: 2.792; 5-y IF: 3.094)
5. Liu J, Liu E, Leng J, Pan L, Zhang C, Li W, Li J, Huo X, Chan JCN, Yu Z, Hu G, Yang X. Indicators of socio-economic status and risk of gestational diabetes mellitus in pregnant women in urban Tianjin, China. Diabetes Res Clin Pract. 2018 Sep 8;144:192-199. doi: 10.1016/j.diabres.2018.08.023. [Epub ahead of print] (2-y IF: 3.239; 5-y IF: 3.587)
6. Li J, Huo X, Cao YF, Li SN, Du Z, Shao P, Leng J, Zhang C, Sun XY, Ma RCW, Fang ZZ*, Yang X*. Bile acid metabolites in early pregnancy and risk of gestational diabetes in Chinese women: A nested case-control study. EBioMedicine. 2018 Sep;35:317-324. doi: 10.1016/j.ebiom.2018.08.015. Epub 2018 Aug 14. (2-y IF: 6.183; 5-y IF:6.112).
7. Li J#, Leng J#, Li W, Zhang C, Feng L, Wang P, Chan JCN, Hu G, Yu Z, Yang X*. Roles of insulin resistance and beta cell dysfunction in macrosomia among Chinese women with gestational diabetes mellitus. Prim Care Diabetes. 2018 December; 12(6):565-573. doi: 10.1016/j.pcd.2018.07.010.(2-y IF: 2.008; 5-y IF: 1.975).
8. Li J#, Cao YF#, Sun XY, Han L, Li SN, Gu WQ, Song M, Jiang CT, Yang X*, Fang ZZ*. Plasma tyrosine and its interaction with low high-density lipoprotein cholesterol and the risk of type 2 diabetes mellitus in Chinese. J Diabetes Investig. 2019 Mar;10(2):491-498. doi: 10.1111/jdi.12898. (2-y IF: 3.902; 5-y IF: 3.641).
9. Li J#, Wang P#, Zhang C, Leng J, Li N, Wang L, Li W, Liu H, Yu Z, Hu G, Chan JCN, Yang X*. Short body height and pre-pregnancy overweight for increased risk of gestational diabetes mellitus: A population-based cohort study. Front Endocrinol (Lausanne).2018 Jun 26;9:349. doi: 10.3389/fendo.2018.00349. eCollection 2018. (2-y IF: 3.643).
10. Lyu Y#, Luo Y#, Li C, Guo X, Lu J, Wu H, Huo X, Gu W, Yang G, Ji L*, Yang X*. Regional differences in the prevalence of coronary heart disease and stroke in patients with type 2 diabetes in China. J Clin Endocrinol Metab.2018 Sept; 103(9): 3319-3330doi.org/10.1210/jc.2018-00422 (2-y IF: 5.605, 5-y IF: 5.960)
11. Song C#, Li W#, Leng J, Wang L, Li W, Shi F, Liu G, Zhou J, Yang X*. Passive smoking and postpartum depression among Chinesewomen: a prospective cohort study in Tianjin, China. WomenHealth. 2018 Jun 20:1-13. doi: 10.1080/**.2018.**. [Epub ahead of print](2-y IF: 1.437; 5-y IF: 1.746)
12. Li J#, Song C, Li C, Liu P, Sun Z,Yang X*. Increased risk of cardiovascular disease in women with prior gestationaldiabetes: A systematic review and meta-analysis. Diabetes Res Clin Pract.2018 Apr 12;140:324-338. doi: 10.1016/ j.diabres. 2018.03. 054.(2-y IF: 3.239; 5-y IF: 3.587)
13. Huo X#, Zhang J#, Guo X, Lu J, Li J, Zhao W, Ji L*,Yang X*. Gender difference in the association of early- vs. late-onset type 2diabeteswith non-fatal microvascular disease in China: A cross-sectional study.Front Endocrinol (Lausanne).2018 Jan 31;9:15. doi: 10.3389/fendo.2018.00015. eCollection 2018.(2-y IF: 3.643).
14. Song C#, Lyu Y#, Li C, Liu P, Li J, Ma RC,Yang X*. Long-term risk ofdiabetesin women at varying durations after gestationaldiabetes: a systematic review and meta-analysis with more than 2 million women.Obes Rev. 2018 Mar;19(3):421-429. doi: 10.1111/obr.12645.(PMID: **; 2-y IF: 8.192; 5-y IF:10.179).
15. Ren Y#, Ren Q#, Lu J, Guo X, Huo X,Ji L*,Yang X*. Low triglyceride as a marker for increased risk of cardiovascular diseases in patients with long-term type 2diabetes: a cross sectional survey in China.DiabetesMetab Res Rev.2018 Feb;34(2):e2960. doi: 10.1002/dmrr.2960. (2-y IF: 4.758; 5-y IF:4.105)
16. Li J#, Luo Y#, Guo X, Huo X, Lu J, Ren Y, Ji L*, Yang X*. Long exposure to type 2 diabetes and risk of non-fatal coronary heart disease in Chinese females andmales: findingsfrom aChinanationalcross-sectionalstudy. DiabetesRes Clin Pract.2018 Mar;137:119-127. doi: 10.1016/j.diabres.2017.10.025.(2-y IF: 3.239; 5-y IF: 3.587)
17. Han Q#, Shao P#,Leng J, Zhang C, Li W, Liu G, Zhang Y, Li Y, Li Z, Ren Y, Chan JC,Yang X*. Interactions between general and central obesity in predicting gestational diabetes mellitus in Chinese pregnant women: A prospective population-based study in Tianjin, China.J Diabetes. 2018 Jan;10(1):59-67. doi: 10.1111/1753-0407.12558. Epub 2017 May 30. (2-y IF: 3.298; 5-y IF: 2.892).
18. Song C#,Leng J#,Wang L,Li W,Zhang S,Wang W,Liu P,Zhang J,Xie B,Li W,Chan JCN,Yang X*. ABO blood types and postpartumdepressionamong Chinese women: A prospective cohort study in Tianjin, China. Women Health.2017 May 22:1-14. doi: 10.1080/**.2017.**. (2-y IF: 1.437; 5-y IF: 1.746)
19. Leng J#, Wang P, Shao P, Zhang C, Li W, Li N, Wang L, Nan H, Yu Z, Hu G, Chan JC, Yang X*. Passive smoking increased risk of gestational diabetes mellitus independently and synergistically with pre-pregnancy obesity in Tianjin, China. Diabetes Metab Res Rev.2017 Mar;33(3):e2861. doi: 10.1002/dmrr.2861.(2-y IF: 3.904; 5-y IF: 3.761)
20. Wang H#, Leng J, Li WQ, Wang L, Zhang C, Li W, Liu H, Zhang S, Chan J, Hu G, Yu Z, Yang X*. Sleep duration and quality, and risk of gestational diabetes mellitus in pregnant Chinese women. Diabet Med.2017 Jan;34(1):44-50. doi: 10.1111/dme.13155(2-y IF: 3.132; 5-y IF: 3.401).
21. Song T#,Luo Y#, Wang X, Li J, Han Q, Zhu H, Zhao W,Li W, Sun Z*,Yang X*. Clinical characteristics of Chinese with over 40 years of duration of type 2 diabetes. J Diabetes. 2017 Jan;9(1):45-52. doi: 10.1111/1753-0407.12375. (2-y IF: 3.213; 5-y IF: 2.764).
22. Ren Y#, Jin N#, Hong T, Mu Y, Guo L, Ji Q, Li Q,Yang X*, Ji L*.Interactive effect of serum uric acidandtotalbilirubinfor cardiovascular disease in Chinese patients with type 2 diabetes. Sci Rep. 2016 Nov 2;6:36437. doi: 10.1038/srep36437.(2-y IF: 4.259; 5-y IF: 4.847).
23. Song C#, Li J, Leng J, Ma RW, Yang X*. Lifestyle intervention can reduce the risk of gestational diabetes: a meta-analysis of randomized controlled trials. Obes Rev.2016 Oct;17(10):960-9.doi: 10.1111/obr.12442.(2-y IF: 7.883; 5-y IF: 9.025).
24. Ren Y#, Ji L#, Mu Y, Hong T*, Ji Q, Guo L, Huang Q, Yang X*. Uric acid, renal function and risk of hypoglycemia in Chinese type 2 diabetespatients. DiabetesMetab Res Rev.2016 Nov;32(8):875-882. doi: 10.1002/dmrr.2809.(2-y IF: 3.263; 5-y IF: 3.550)
25. Leng J#, Zhang C, Wang P, Li N, Li W, Liu H, Zhang S, Hu G, Yu Z, Ma RC, Chan JC, Yang X*.Plasma levels of alanine aminotransferase in the first trimester identify high risk Chinese women for gestational diabetes.Sci Rep. 2016 Jun 6;6:27291. doi: 10.1038/srep27291. (2-y IF: 4.259; 5-y IF: 4.847).
26. Leng J#, Liu G, Zhang C, Xin S, Chen F, Li B, Tian H, Yu Z, Tuomilehto J, Hu G, YangX*. Physical activity, sedentary behaviors and risk of gestational diabetes mellitus in Chinese pregnant women. Eur J Endocrinol.2016 Jun;174(6):763-73. doi: 10.1530/EJE-15-1103. (2-y IF:4.101; 5-y IF: 4.142)
27. Wei F#, Sun N#, Cai C#, Feng S#, Tian J, Shi W, Xu W, Wang Y*,Yang X*, Li WD*. Associations between serum uric acid and the incidence of hypertension: a Chinese senior dynamic cohort study. J Transl Med. 2016 Apr 30;14(1):110. doi: 10.1186/s12967-016-0866-0. (2-y IF: 3.786; 5-y IF: 4.261)
28. Gu W#, Ren Y#, Ji L, Hong T*, Mu Y, Guo L, Li Q, Tian Q, Yang X*.Non-linear associations of risk factors with hypoglycaemia among Chinese patients with type 2 diabetes. J DiabetesComplications.2016Apr;30(3):462-8. doi: 10.1016/j.jdiacomp.2015.12.024. Epub 2015 Dec 29. (2-y IF: 2.734; 5-y IF: 2.814)
29. HuoX#,GaoL#, GuoL#, XuW, WangW, ZhiX, LiL, RenY, QiX, SunZ,LiW,JiQ, RanX, SuB, HaoC, LuJ, GuoX, ZhuoH, ZhangD, PanC, WengJ,HuD, YangX*,JiL*.Risk of non-fatal cardiovascular diseases in early-onset versus late-onset type 2 diabetesin China: a cross-sectional study. Lancet DiabetesEndocrinol.2016 Feb;4(2):115-24. doi: 10.1016/S2213-8587(15)00508-2. (2-y IF: 19.742; 5-y IF: 19.337)
30. Li Y#, Mu Y#, Ji Q, HuangQ, KuangH, JiL*, YangX*. Hypoglycemia, Abnormal Lipids and Cardiovascular Disease among Chinese with Type 2 Diabetes. Biomed Res Int. 2015;2015:862896.DOI: 10.1155/2015/862896. (2-y IF: 2.134; 5-y IF: 2.149)
31. Pan L, Leng J, Liu G, Zhang C, Liu H, Li M, Tan L, Tian H, Chan JC, Hu G, Yu Z, Yang X*.Pregnancyoutcomes of Chinese women with gestational diabetes mellitus defined by the IADPSG’s but not by the 1999 WHO’s criteria.Clin Endocrinol (Oxf). 2015 Nov;83(5):684-93. 22 APR 2015.DOI: 10.1111/cen.12801. (2-y IF: 3.487; 5-y IF: 3.469)
32. Zhang C, Li Y, Wang L, Sun S, Liu G, Leng J, Guo J, Lv L, Li W, Zhang C, Hu G, Yu Z, Yang X*.ABO blood groups and gestational diabetes mellitus: a prospective population-based study in Tianjin, China.Diabetes Metab Res Rev.2015 Sept; 31(6): 627-37. doi: 10.1002/dmrr.2650. [Epub ahead of print](2-y IF: 3.064; 5-y IF: 3.461)
33. Leng J, Shao P, Zhang C, Tian H, Zhang F, Zhang S, Dong L,Li L,YuZ, Chan JC, Hu G, YangX*. Prevalence of gestational diabetes mellitus and its risk factors in Chinese pregnant women: a prospective population-based study in Tianjin, China. PLoS One. 2015 Mar 23;10(3):e**. doi: 10.1371/journal.pone.**. eCollection 2015.(2-y IF: 3.057; 5-y IF: 3.535)
34. Yang X#,*, Lee HM, Chan JC#,*. Drug-Subphenotype Interactions for Cancer in Type 2 Diabetes. Nat Rev Endocrinol.2015 Jun;11(6):372-379. doi: 10.1038/nrendo.2015.37. Epub 2015 Mar 24.(2-y IF: 15.432; 5-y IF: 14.125)
35. GuoXH#, WengJP#, Lu JM, YangWY, Jia WP, Zou DJ, Zhou ZG, Zhu D, Ji QH, Shi LX, Ji LN*,, YangXL*.Determinants of Poor Glycemic Control in Chinese Men with Type 2 Diabetes: A Cross Sectional Survey of 15427 Men in 77 Tertiary Hospitals in China. International Journal of Diabetes in Developing Countries.2015;35(4):488-492. DOI: 10.1007/s13410-015-0322-3.(2-y IF: 0.366; 5-y IF:0.494)
36. LiL#, JiLN#, GuoXH,JiQH,GuWJ,ZhiXY,LiX,KuangHY,SuBL,YanJH,YangXL*.Prevalence of microvascular diseases among tertiary care Chinese with early versus late onset of type 2Diabetes.J DiabetesComplications.2015 Jan-Feb;29(1):32-7. doi: 10.1016/j.jdiacomp.2014.08.010. Epub 2014 Sep 3.(2-y IF: 2.955; 5-y IF: 2.732)
37. Yang X*, Tian H, Zhang F, Zhang C, Li Y, Leng J, Wang L, Liu G, Dong L, Yu Z, Hu G, Chan JC.A randomised translational trial of lifestyle intervention using a 3-tier shared care approach on pregnancy outcomes in Chinese women with gestational diabetes mellitus but without diabetes.J Transl Med.2014 Oct 28;12:290. doi: 10.1186/s12967-014-0290-2.(2-y IF: 3.930; 5-y IF:4.126)
38. Lu J#,WengJ#, GuW,GuoX,Yang W,Zou D,Zhou Z,Zhu D,Ji Q, Ji L*, Yang X*. Non-Pharmaceutical Factors for Poor Glycaemic Controlin 13970 Chinese Women with Drug-Treated Type 2 Diabetes: A Cross Sectional Survey in 77 Tertiary Hospitals in Four Chinese Cities. Patient Preference and Adherence.2014;8:1161-7(2-y IF: 1.676; 5-y IF:1.721)
39. Ji L#,*Weng J#, Lu J, Guo X, Yang W, Jia W, Zou D, Zhou Z, Zhu D, Ji Q, Shi L, Yang X*.Hyperglycemia and duration of diabetes as risk factors for abnormal lipids: a cross sectional survey of 19,757 patients with type 2 diabetes in China.J Endocrinol Invest. 2014;37(9): 843-852. DOI: 10.1007/s40618-014-0115-4. (2-y IF: 1.448; 5-y IF:1.684)
40. Yang X*, Wang Y, Luk AO, So WY, Ma RC, Kong AP, Xu G, Chan JC*.Renin Angiotensin System Inhibitors May Attenuate Low LDL Cholesterol-Related Cancer Risk in Type 2 Diabetes. Diabetes Metab Res Rev2014 Jul;30(5):415-23. doi: 10.1002/dmrr.2504.(2-y IF: 3.553; 5-y IF:3.416)
41. Kong AP#,*, Yang X#, Luk A, Cheung KK, Ma RC, So WY, Ho CS, Chan MH, Ozaki R, Chow CC, Brown N, Chan JC*. Hypoglycaemia, chronic kidney disease and death in type 2 diabetes: the Hong Kong diabetes registry. BMC Endocrine Disorders2014 Jun 13;14(1):48. [Epub ahead of print]. (2-y IF: 1.710; 5-y IF:2.187)
42. Kong AP#, Yang X#, So WY, Luk A, Ma RC, Ozaki R, Cheung KK, Lee HM, Yu L, Xu G, Chow CC, Chan JC*. Additive effects of blood glucose lowering drugs, statins and renin-angiotensin system blockers on all-site cancer risk in patients with type 2 diabetes. BMC Medicine2014 May 13;12(1):76. doi: 10.1186/1741-7015-12-76.(2-y IF: 7.356; 5-y IF:7.770)
43. Yang XL*, Kong AP, Luk A, Ozaki R, Ko GTC, Ma RCW, Chan JCN*, So WY. Validation of methods to control for immortal time bias in pharmacoepidemiological analysis of RAS inhibitors in Type 2 diabetes. Journal of Epidemiology 2014;24(4):267-73.DOI: http://dx.doi.org/10.2188/jea.JE**. (2-y IF: 3.022; 5-y IF:2.592)
44. Kong AP#,*, Yang XL#, Luk A, Ma RCW, So WY, Ozaki R, Ting R, CheungK, Ho CS, Chan MH,Chow CC, Chan JCN. Severe hypoglycaemia identifies vulnerable patients with Type 2 diabetes at risk of premature death and all-site cancer: the Hong Kong diabetes registry. Diabetes Care 2014 Apr;37(4):1024-31. doi: 10.2337/dc13-2507. Epub 2014 Feb 10.(2-y IF: 8.420; 5-y IF:8.569)
45. Weng J#,*, Yang X#,*. Unsubstantiated concerns over the safety of use of sulphonylureas and insulin for increased risk of diabetes complications.J Diabetes. 2014 Jan;6(1):30-2. doi: 10.1111/1753-0407.12082. Epub 2013 Sep 18.(2-y IF: 1.932; 5-y IF:2.381)
研究生培养情况
博士生毕业3名，在职1名
硕士生毕业9名，在职4名
招生专业
流行病学
社会兼职
天津市心脏学会流行病专业委员会副主委
天津市临床流行病与循证医学会副主委
天津市预防医学会理事
